Back to search

Article

Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents

2024-12-09

Abstract excerpt

Herpes simplex virus (HSV) infection has worldwide public health concerns and lifelong medical impacts. The standard therapy, acyclovir, has limited efficacy in preventing HSV subclinical virus shedding, and drug resistance occurs in immunocompromised patients, highlighting the need for novel therapeutics. HSV manifests in the skin and mucosal epithelium. Here, we found acyclovir significantly less effective in sk...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22611bdc-fa5a-5d31-9c55-eb3a64e026d9
DOI
10.1101/2024.12.04.626896
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalentsDOI 10.1101/2024.12.04.626896
Select a neighboring publication to make it the new centre.